Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Diabetes and Obesity

Volume 2

eBook: US $39 Special Offer (PDF + Printed Copy): US $138
Printed Copy: US $119
Library License: US $156
ISSN: 2467-9607 (Print)
ISSN: 2352-3220 (Online)
ISBN: 978-1-68108-186-1 (Print)
ISBN: 978-1-68108-185-4 (Online)
Year of Publication: 2017
DOI: 10.2174/97816810818541160201


Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.

The second volume of this series features 7 reviews presenting updates on hormones and several classes of drugs:

  • - Osteocalcin action in glucose metabolism
  • - Sodium-glucose co-transporter 2 (SGLT2) inhibitors
  • - Glucagon-like peptide-1 (GLP-1) mimetics
  • - Dipeptidyl peptidase 4 (DPP-4) inhibitors
  • - New drugs in clinical trial and commercial phases


- Pp. i
Download Free

List of Contributors

- Pp. iii
Download Free

The Current, Emerging and Future Medications for Type 2 Diabetes and Obesity

- Pp. 3-49 (47)
Hidesuke Kaji
View Abstract

Antidiabetic Drugs of Type 2 Diabetes and Obesity

- Pp. 50-59 (10)
Tatjana Ábel, Gabriella Lengyel
View Abstract

Sodium-Glucose Co-Transport Inhibitors: A New Therapeutic Option for Type 2 Diabetes Mellitus

- Pp. 60-83 (24)
Athanasia K. Papazafiropoulou, Marina S. Kardara
View Abstract

Osteocalcin Plays as an Endocrine Hormone in Glucose Metabolism

- Pp. 84-101 (18)
Ippei Kanazawa
View Abstract

Emerging Therapeutic Agents for the Treatment of Type 2 Diabetes Mellitus

- Pp. 102-149 (48)
Shivaprasad Channabasappa, Krishnan M. Prasanna Kumar
View Abstract

Advances in New Drugs for Diabetes Treatment: GLP-1 Mimetics and DPP-4 Inhibitors

- Pp. 150-188 (39)
Xianglan Sun, Yao Wang, Minglong Li
View Abstract

New and Promising Drugs for Obesity

- Pp. 189-234 (46)
Natalia G. Vallianou, Angelos A. Evangelopoulos, Christos E. Kazazis
View Abstract

Subject Index

- Pp. 235-243 (9)
Download Free


.Diabesity: A Multidisciplinary Approach.
.Pharmacological and Molecular Perspectives on Diabetes.
.Frontiers in Clinical Drug Research – Diabetes and Obesity.
.Phytotherapy in the Management of Diabetes and Hypertension.